BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12660519)

  • 1. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
    Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
    Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA amino acid residue matching.
    Takemoto SK
    Clin Transpl; 1996; ():397-425. PubMed ID: 9286585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty.
    Böhringer D; Reinhard T; Duquesnoy RJ; Böhringer S; Enczmann J; Lange P; Claas F; Sundmacher R
    Transplantation; 2004 Feb; 77(3):417-21. PubMed ID: 14966417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.
    Duquesnoy RJ
    Hum Immunol; 2002 May; 63(5):339-52. PubMed ID: 11975978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview and epitope matching.
    Terasaki PI; Park MS; Takemoto S; Cecka JM; Clark B; Corcoran S; Cicciarelli J; Barbetti A; Yuge J; Carnahan E
    Clin Transpl; 1989; ():499-516. PubMed ID: 2484860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.
    Duquesnoy RJ
    Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HLA matching on renal transplant survival.
    Zhou YC; Cecka JM
    Clin Transpl; 1993; ():499-510. PubMed ID: 7918184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation.
    Laux G; Mytilineos J; Opelz G
    Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA matching: identification of permissible HLA mismatches.
    Maruya E; Takemoto S; Terasaki PI
    Clin Transpl; 1993; ():511-20. PubMed ID: 7918185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigens DR and AB and kidney retransplantation.
    Thompson JS; Thacker LR; Krishnan G
    Transplantation; 2003 Mar; 75(5):718-23. PubMed ID: 12640315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA compatibility can be predicted by matching only three residues with outward oriented sidechains.
    Takemoto S; Terasaki PI
    Transplant Proc; 1996 Jun; 28(3):1264-6. PubMed ID: 8658652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
    Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
    Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UNOS Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 2002; ():1-20. PubMed ID: 12971433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.